HLB Therapeutics Co.,Ltd.
115450
Rangering i aksjer
#18742
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Aksjekurs
$1.88
Markedsverdi
$176.93M
Endring (1 dag)
-0.18%
Endring (1 år)
-10.47%
Land
KR
Handel HLB Therapeutics Co.,Ltd. (115450)
Kategori
Healthcare
Markedsverdi av HLB Therapeutics Co.,Ltd.(115450)
Markedsverdi: $176.93M
Per October 2026 har HLB Therapeutics Co.,Ltd. en markedsverdi på $176.93M. Dette gjør HLB Therapeutics Co.,Ltd. til det 18742nd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for HLB Therapeutics Co.,Ltd. fra 2010 til 2026
115450 sammenlignet med topp 5 mest populære stocks
